应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GELS Gelteq
已收盘 01-02 16:00:00 EST
0.8377
+0.0377
+4.71%
盘后
0.8377
+0.0000
0.00%
18:51 EST
最高
0.8500
最低
0.7829
成交量
1.46万
今开
0.8285
昨收
0.8000
日振幅
8.39%
总市值
897.27万
流通市值
399.80万
总股本
1,071万
成交额
1.18万
换手率
0.31%
流通股本
477.26万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Gelteq与深圳Mana健康管理有限公司签署三年销售协议,强化Gelteq营养产品在中国的扩展
美股速递 · 2025-12-09
Gelteq与深圳Mana健康管理有限公司签署三年销售协议,强化Gelteq营养产品在中国的扩展
Gelteq有限公司:预计将利用这些结果进一步推进抗组胺产品的FDA审批进程
美股速递 · 2025-11-24
Gelteq有限公司:预计将利用这些结果进一步推进抗组胺产品的FDA审批进程
Gelteq公布积极的临床前结果,展示其专有凝胶药物递送平台的生物利用度提升
美股速递 · 2025-11-24
Gelteq公布积极的临床前结果,展示其专有凝胶药物递送平台的生物利用度提升
Gelteq Limited盘中异动 股价大跌6.69%报0.851美元
市场透视 · 2025-11-21
Gelteq Limited盘中异动 股价大跌6.69%报0.851美元
Gelteq宣布与墨尔本健康中心达成新型肠道息肉抑制化合物产品开发协议
美股速递 · 2025-10-09
Gelteq宣布与墨尔本健康中心达成新型肠道息肉抑制化合物产品开发协议
Gelteq宣布启动新型凝胶抗组胺药物制剂临床前试验,目标过敏症市场
美股速递 · 2025-09-05
Gelteq宣布启动新型凝胶抗组胺药物制剂临床前试验,目标过敏症市场
Citius Oncology, Inc.盘中异动 早盘股价大涨5.10%
市场透视 · 2025-07-17
Citius Oncology, Inc.盘中异动 早盘股价大涨5.10%
Talphera, Inc.盘中异动 大幅跳水6.23%报0.403美元
市场透视 · 2025-07-17
Talphera, Inc.盘中异动 大幅跳水6.23%报0.403美元
Gelteq Limited7月8日成交额为233.53万美元
市场透视 · 2025-07-09
Gelteq Limited7月8日成交额为233.53万美元
Citius Oncology, Inc.盘中异动 大幅跳水6.58%
市场透视 · 2025-07-09
Citius Oncology, Inc.盘中异动 大幅跳水6.58%
Evoke Pharma, Inc.盘中异动 急速拉升5.28%
市场透视 · 2025-07-09
Evoke Pharma, Inc.盘中异动 急速拉升5.28%
Talphera, Inc.盘中异动 下午盘股价大涨5.83%报0.490美元
市场透视 · 2025-07-09
Talphera, Inc.盘中异动 下午盘股价大涨5.83%报0.490美元
Gelteq Limited7月7日成交额为21.94万美元
市场透视 · 2025-07-08
Gelteq Limited7月7日成交额为21.94万美元
Gelteq Limited7月3日成交额为5.82万美元
市场透视 · 2025-07-04
Gelteq Limited7月3日成交额为5.82万美元
Gelteq Limited7月2日成交额为4.02万美元
市场透视 · 2025-07-03
Gelteq Limited7月2日成交额为4.02万美元
Harrow, Inc.盘中异动 下午盘大幅下挫5.07%
市场透视 · 2025-01-23
Harrow, Inc.盘中异动 下午盘大幅下挫5.07%
Shuttle Pharmaceuticals Holdings, Inc.盘中异动 快速拉升5.91%报0.932美元
市场透视 · 2025-01-23
Shuttle Pharmaceuticals Holdings, Inc.盘中异动 快速拉升5.91%报0.932美元
美国OTC市场讴歌制药公司盘中异动 股价大涨110.00%
市场透视 · 2025-01-23
美国OTC市场讴歌制药公司盘中异动 股价大涨110.00%
Talphera, Inc.盘中异动 股价大涨7.11%报0.675美元
市场透视 · 2025-01-23
Talphera, Inc.盘中异动 股价大涨7.11%报0.675美元
美国OTC市场Santen Pharmaceutical Co盘中异动 早盘快速下跌5.15%
市场透视 · 2025-01-23
美国OTC市场Santen Pharmaceutical Co盘中异动 早盘快速下跌5.15%
加载更多
公司概况
公司名称:
Gelteq
所属市场:
NASDAQ
上市日期:
--
主营业务:
Gelteq Limited于2018年10月15日根据澳大利亚维多利亚州的法律成立。他们是一家以临床和科学为基础的公司,专注于为处方药、保健品、宠物护理和其他产品。“白标”凝胶交付解决方案是他们生产的产品,其他公司将其重新命名为自己的产品。他们的主要产品是可食用凝胶,他们将其称为凝胶,以及它们在基于凝胶的剂型中的应用。当前的产品套件包括多个产品,这些产品位于五个核心垂直领域——宠物、运动、制药(制药)、非处方药(OTC)和营养品——所有这些产品都利用了正在申请专利的多成分剂型,以及他们期望拥有广泛的应用程序和消费者。他们目前的重点是将该技术授权给公司,以开发和创造他们可以在其已建立和研究的市场内制造和销售的新产品,同时他们继续根据许可(“白标”)制造现有产品。
发行价格:
--
{"stockData":{"symbol":"GELS","market":"US","secType":"STK","nameCN":"Gelteq","latestPrice":0.8377,"timestamp":1767387600000,"preClose":0.8,"halted":0,"volume":14567,"hourTrading":{"tag":"盘后","latestPrice":0.8377,"preClose":0.8377,"latestTime":"18:51 EST","volume":80,"amount":67.017096,"timestamp":1767397876194},"delay":0,"floatShares":4772600,"shares":10711059,"eps":-0.4627,"marketStatus":"已收盘","change":0.0377,"latestTime":"01-02 16:00:00 EST","open":0.8285,"high":0.85,"low":0.7829,"amount":11836.442944620001,"amplitude":0.083875,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.4627,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1767603600000},"marketStatusCode":5,"adr":0,"listingDate":1710129600000,"exchange":"NASDAQ","adjPreClose":0.8,"postHourTrading":{"tag":"盘后","latestPrice":0.8377,"preClose":0.8377,"latestTime":"18:51 EST","volume":80,"amount":67.017096,"timestamp":1767397876194},"volumeRatio":0.507084},"requestUrl":"/m/hq/s/GELS","defaultTab":"news","newsList":[{"id":"1134246373","title":"Gelteq与深圳Mana健康管理有限公司签署三年销售协议,强化Gelteq营养产品在中国的扩展","url":"https://stock-news.laohu8.com/highlight/detail?id=1134246373","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134246373?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:15","pubTimestamp":1765289718,"startTime":"0","endTime":"0","summary":"Gelteq与深圳Mana健康管理有限公司签署三年销售协议,强化Gelteq营养产品在中国的扩展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"1199035166","title":"Gelteq有限公司:预计将利用这些结果进一步推进抗组胺产品的FDA审批进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1199035166","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199035166?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:34","pubTimestamp":1763991277,"startTime":"0","endTime":"0","summary":"Gelteq有限公司:预计将利用这些结果进一步推进抗组胺产品的FDA审批进程","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"1108560078","title":"Gelteq公布积极的临床前结果,展示其专有凝胶药物递送平台的生物利用度提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1108560078","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108560078?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:31","pubTimestamp":1763991074,"startTime":"0","endTime":"0","summary":"Gelteq公布积极的临床前结果,展示其专有凝胶药物递送平台的生物利用度提升","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2585648041","title":"Gelteq Limited盘中异动 股价大跌6.69%报0.851美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585648041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585648041?lang=zh_cn&edition=full","pubTime":"2025-11-21 01:21","pubTimestamp":1763659304,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日01时21分,Gelteq Limited股票出现异动,股价急速下跌6.69%。截至发稿,该股报0.851美元/股,成交量5.5328万股,换手率0.55%,振幅11.36%。Gelteq Limited股票所在的制药行业中,整体跌幅为0.49%。Gelteq Limited公司简介:Gelteq Ltd是一家以临床和科学为基础的公司,专注于开发和商业化基于白标凝胶的给药解决方案,以保持口服给药的简便性,可及性和有效性,而不存在传统上与其他口服给药方法相关的障碍,如处方药,营养药品,宠物护理和其他产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121012144a4afb7f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121012144a4afb7f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"1115941035","title":"Gelteq宣布与墨尔本健康中心达成新型肠道息肉抑制化合物产品开发协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1115941035","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115941035?lang=zh_cn&edition=full","pubTime":"2025-10-09 20:04","pubTimestamp":1760011493,"startTime":"0","endTime":"0","summary":"Gelteq宣布与墨尔本健康中心达成新型肠道息肉抑制化合物产品开发协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"1191942832","title":"Gelteq宣布启动新型凝胶抗组胺药物制剂临床前试验,目标过敏症市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1191942832","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191942832?lang=zh_cn&edition=full","pubTime":"2025-09-05 23:29","pubTimestamp":1757086159,"startTime":"0","endTime":"0","summary":"Gelteq宣布启动新型凝胶抗组胺药物制剂临床前试验,目标过敏症市场","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2552484012","title":"Citius Oncology, Inc.盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552484012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552484012?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:44","pubTimestamp":1752759894,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时44分,Citius Oncology, Inc.股票出现波动,股价快速上涨5.10%。Citius Oncology, Inc.股票所在的制药行业中,整体跌幅为0.66%。其相关个股中,Scilex Holding Company C/Wts 10/11/2027 、Medicus Pharma Ltd C/Wts 15/11/2029、Scilex Holding Company涨幅较大,Incannex Healthcare Inc.、Gelteq Limited、Shuttle Pharmaceuticals Holdings, Inc.较为活跃,换手率分别为31.47%、6.73%、4.23%,振幅较大的相关个股有Im Cannabis Corp.、Gelteq Limited、Durect Corporation,振幅分别为10.49%、9.68%、7.16%。Citius Oncology, Inc.公司简介:Citius Oncology Inc 是一家专业制药公司,致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214454a451453c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214454a451453c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","GELS","BK4007","BK4139"],"gpt_icon":0},{"id":"2552680482","title":"Talphera, Inc.盘中异动 大幅跳水6.23%报0.403美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552680482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552680482?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:33","pubTimestamp":1752759209,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时33分,Talphera, Inc.股票出现异动,股价快速下跌6.23%。截至发稿,该股报0.403美元/股,成交量1.8116万股,换手率0.09%,振幅0.67%。Talphera, Inc.股票所在的制药行业中,整体跌幅为0.65%。Talphera, Inc.公司简介:Talphera Inc. 是一家专注于开发和商业化在医疗监督下使用的疗法的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213329954638c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213329954638c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GELS","TLPH"],"gpt_icon":0},{"id":"2550248503","title":"Gelteq Limited7月8日成交额为233.53万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550248503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550248503?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:13","pubTimestamp":1752027210,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日,Gelteq Limited成交额为233.53万美元,成交额较昨日增加964.47%,当日成交量为130.43万股。Gelteq Limited于2025年7月8日涨13.77%,报1.9美元,该股过去5个交易日涨9.83%,年初至今跌18.1%,过去60日涨110.64%。该公司致力于开发和测试一种用于人类和宠物的凝胶型给药系统。其主要产品是食用凝胶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709101334a43f293e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709101334a43f293e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2550520286","title":"Citius Oncology, Inc.盘中异动 大幅跳水6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550520286?lang=zh_cn&edition=full","pubTime":"2025-07-09 03:16","pubTimestamp":1752002211,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日03时16分,Citius Oncology, Inc.股票出现波动,股价急速跳水6.58%。Citius Oncology, Inc.股票所在的制药行业中,整体涨幅为0.57%。其相关个股中,Rockwell Medical, Inc.、Gelteq Limited、Tilray Brands, Inc.涨幅较大,Incannex Healthcare Inc.、Shuttle Pharmaceuticals Holdings, Inc.、Gelteq Limited较为活跃,换手率分别为31.27%、15.37%、12.27%,振幅较大的相关个股有Gelteq Limited、Sunshine Biopharma Inc C/Wts 、Rockwell Medical, Inc.,振幅分别为28.14%、22.77%、20.01%。Citius Oncology, Inc.公司简介:Citius Oncology Inc 是一家专业制药公司,致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709031651979eb13d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709031651979eb13d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CTOR","GELS","BK4139"],"gpt_icon":0},{"id":"2550527913","title":"Evoke Pharma, Inc.盘中异动 急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550527913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550527913?lang=zh_cn&edition=full","pubTime":"2025-07-09 02:09","pubTimestamp":1751998163,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时09分,Evoke Pharma, Inc.股票出现波动,股价急速上涨5.28%。Evoke Pharma, Inc.股票所在的制药行业中,整体涨幅为0.44%。其相关个股中,Rockwell Medical, Inc.、Tilray Brands, Inc.、Biofrontera Inc.涨幅较大,Incannex Healthcare Inc.、Shuttle Pharmaceuticals Holdings, Inc.、Gelteq Limited较为活跃,换手率分别为28.84%、14.80%、11.79%,振幅较大的相关个股有Gelteq Limited、Sunshine Biopharma Inc C/Wts 、Medicus Pharma Ltd.,振幅分别为27.54%、22.60%、18.82%。Evoke Pharma, Inc.公司简介:Evoke Pharma Inc 是一家专业制药公司,专注于治疗胃肠道疾病的药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709020924a69da125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709020924a69da125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GELS","EVOK","BK4007"],"gpt_icon":0},{"id":"2550522821","title":"Talphera, Inc.盘中异动 下午盘股价大涨5.83%报0.490美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550522821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550522821?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:02","pubTimestamp":1751994127,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日01时02分,Talphera, Inc.股票出现波动,股价大幅拉升5.83%。截至发稿,该股报0.490美元/股,成交量1.9883万股,换手率0.10%,振幅4.32%。Talphera, Inc.股票所在的制药行业中,整体涨幅为0.63%。Talphera, Inc.公司简介:Talphera Inc. 是一家专注于开发和商业化在医疗监督下使用的疗法的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709010207a43e78a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709010207a43e78a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GELS","TLPH"],"gpt_icon":0},{"id":"2549598669","title":"Gelteq Limited7月7日成交额为21.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549598669","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549598669?lang=zh_cn&edition=full","pubTime":"2025-07-08 10:12","pubTimestamp":1751940730,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日,Gelteq Limited成交额为21.94万美元,成交额较昨日增加276.67%,当日成交量为12.88万股。Gelteq Limited于2025年7月7日跌2.91%,报1.67美元,该股过去5个交易日跌7.73%,年初至今跌28.02%,过去60日涨87.85%。其主要产品是食用凝胶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708101218a69c0bcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708101218a69c0bcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2548833720","title":"Gelteq Limited7月3日成交额为5.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548833720","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548833720?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:13","pubTimestamp":1751595234,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日,Gelteq Limited成交额为5.82万美元,成交额较昨日增加44.79%,当日成交量为3.33万股。Gelteq Limited于2025年7月3日跌1.71%,报1.72美元,该股过去5个交易日跌8.51%,年初至今跌25.86%,过去60日涨82.98%。其主要产品是食用凝胶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704101402a72dc409&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704101402a72dc409&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2548382879","title":"Gelteq Limited7月2日成交额为4.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548382879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548382879?lang=zh_cn&edition=full","pubTime":"2025-07-03 10:12","pubTimestamp":1751508767,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Gelteq Limited成交额为4.02万美元,成交额较昨日增加15.13%,当日成交量为2.32万股。Gelteq Limited于2025年7月2日跌0.57%,报1.75美元,该股过去5个交易日跌8.85%,年初至今跌24.57%,过去60日涨94.23%。其主要产品是食用凝胶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703101254a72ba437&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703101254a72ba437&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2505708710","title":"Harrow, Inc.盘中异动 下午盘大幅下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505708710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505708710?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:06","pubTimestamp":1737576405,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时06分,Harrow, Inc.股票出现异动,股价快速跳水5.07%。Harrow, Inc.股票所在的制药行业中,整体涨幅为0.72%。其相关个股中,Gelteq Limited、博美集团、Talphera, Inc.涨幅较大,Gelteq Limited、Inmed Pharmaceuticals Inc.、Painreform Ltd.较为活跃,换手率分别为76.24%、75.64%、7.23%,振幅较大的相关个股有博美集团、Gelteq Limited、Sunshine Biopharma Inc C/Wts ,振幅分别为28.60%、26.19%、22.42%。Harrow, Inc.公司简介:Harrow Inc 是一家眼科制药公司,致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123040646986faa8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123040646986faa8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4007","HROW","GELS"],"gpt_icon":0},{"id":"2505770834","title":"Shuttle Pharmaceuticals Holdings, Inc.盘中异动 快速拉升5.91%报0.932美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505770834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505770834?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:00","pubTimestamp":1737576058,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时00分,Shuttle Pharmaceuticals Holdings, Inc.股票出现波动,股价快速上涨5.91%。Shuttle Pharmaceuticals Holdings, Inc.股票所在的制药行业中,整体涨幅为0.77%。其相关个股中,Gelteq Limited、博美集团、Talphera, Inc.涨幅较大,Gelteq Limited、Inmed Pharmaceuticals Inc.、Painreform Ltd.较为活跃,换手率分别为76.21%、74.70%、7.22%,振幅较大的相关个股有博美集团、Gelteq Limited、Sunshine Biopharma Inc C/Wts ,振幅分别为28.60%、26.19%、22.42%。Shuttle Pharmaceuticals Holdings, Inc.公司简介:Shuttle Pharmaceuticals Holdings Inc 是一家临床阶段的制药公司,利用我们的专有技术开发旨在治愈癌症的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123040058986fa97f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123040058986fa97f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GELS","BK4007","SHPH"],"gpt_icon":0},{"id":"2505776708","title":"美国OTC市场讴歌制药公司盘中异动 股价大涨110.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505776708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505776708?lang=zh_cn&edition=full","pubTime":"2025-01-23 01:31","pubTimestamp":1737567061,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日01时31分,美国OTC市场讴歌制药公司股票出现波动,股价大幅拉升110.00%。截至发稿,该股报0.002美元/股,成交量760股,换手率0.00%,振幅0.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场讴歌制药公司股票所在的制药行业中,整体涨幅为0.73%。美国OTC市场讴歌制药公司公司简介:讴歌制药公司是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123013101a22bd767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123013101a22bd767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GELS","ACUR"],"gpt_icon":0},{"id":"2505388775","title":"Talphera, Inc.盘中异动 股价大涨7.11%报0.675美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505388775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505388775?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:55","pubTimestamp":1737564947,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时55分,Talphera, Inc.股票出现异动,股价急速拉升7.11%。截至发稿,该股报0.675美元/股,成交量3.6515万股,换手率0.21%,振幅4.68%。Talphera, Inc.股票所在的制药行业中,整体涨幅为0.79%。Talphera, Inc.公司简介:Talphera Inc. 是一家制药公司,专注于在医疗监督环境中使用的疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123005547960d16b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123005547960d16b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GELS","TLPH"],"gpt_icon":0},{"id":"2505200107","title":"美国OTC市场Santen Pharmaceutical Co盘中异动 早盘快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505200107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505200107?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:20","pubTimestamp":1737562803,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时20分,美国OTC市场Santen Pharmaceutical Co股票出现波动,股价快速下跌5.15%。截至发稿,该股报9.77美元/股,成交量1.0005万股,换手率0.00%,振幅0.00%。美国OTC市场Santen Pharmaceutical Co股票所在的制药行业中,整体涨幅为0.85%。其相关个股中,Gelteq Limited、博美集团、Sunshine Biopharma Inc C/Wts 涨幅较大,Gelteq Limited、Inmed Pharmaceuticals Inc.、Painreform Ltd.较为活跃,换手率分别为70.09%、56.65%、4.12%,振幅较大的相关个股有博美集团、Gelteq Limited、Medicus Pharma Ltd.,振幅分别为28.60%、26.19%、20.79%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123002003960d116c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123002003960d116c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNPHY","GELS","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gelteq.com","stockEarnings":[{"period":"1week","weight":-0.0805},{"period":"1month","weight":-0.2308},{"period":"3month","weight":-0.3548},{"period":"6month","weight":-0.5349},{"period":"1year","weight":-0.6552},{"period":"ytd","weight":-0.6552}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.019},{"period":"6month","weight":0.0905},{"period":"1year","weight":0.1635},{"period":"ytd","weight":0.1635}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gelteq Limited于2018年10月15日根据澳大利亚维多利亚州的法律成立。他们是一家以临床和科学为基础的公司,专注于为处方药、保健品、宠物护理和其他产品。“白标”凝胶交付解决方案是他们生产的产品,其他公司将其重新命名为自己的产品。他们的主要产品是可食用凝胶,他们将其称为凝胶,以及它们在基于凝胶的剂型中的应用。当前的产品套件包括多个产品,这些产品位于五个核心垂直领域——宠物、运动、制药(制药)、非处方药(OTC)和营养品——所有这些产品都利用了正在申请专利的多成分剂型,以及他们期望拥有广泛的应用程序和消费者。他们目前的重点是将该技术授权给公司,以开发和创造他们可以在其已建立和研究的市场内制造和销售的新产品,同时他们继续根据许可(“白标”)制造现有产品。","exchange":"NASDAQ","name":"Gelteq","nameEN":"Gelteq"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gelteq(GELS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gelteq(GELS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gelteq,GELS,Gelteq股票,Gelteq股票老虎,Gelteq股票老虎国际,Gelteq行情,Gelteq股票行情,Gelteq股价,Gelteq股市,Gelteq股票价格,Gelteq股票交易,Gelteq股票购买,Gelteq股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gelteq(GELS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gelteq(GELS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}